BOSTON SCIENTIFIC CORPORATION Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax
BOSTON SCIENTIFIC CORPORATION (BSX) reported Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax of -$8.00 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-23.
Discontinued › Notes › Derivative Instruments and Hedging Activities › Summary of Derivative Instruments › Summary of Derivative Instruments by Hedge Designation
us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax · last filed 2023-02-23
- BOSTON SCIENTIFIC CORPORATION gain (loss) on derivative used in net investment hedge, after tax for the quarter ending 2020-12-31 was -$5.00M.
- BOSTON SCIENTIFIC CORPORATION gain (loss) on derivative used in net investment hedge, after tax for the quarter ending 2020-09-30 was -$5.00M.
- BOSTON SCIENTIFIC CORPORATION gain (loss) on derivative used in net investment hedge, after tax for the quarter ending 2020-06-30 was -$5.00M.
- BOSTON SCIENTIFIC CORPORATION gain (loss) on derivative used in net investment hedge, after tax for the quarter ending 2020-03-31 was -$5.00M.
- BOSTON SCIENTIFIC CORPORATION gain (loss) on derivative used in net investment hedge, after tax for fiscal 2022 was -$8.00M.
- BOSTON SCIENTIFIC CORPORATION gain (loss) on derivative used in net investment hedge, after tax for fiscal 2021 was -$137.00M.
- BOSTON SCIENTIFIC CORPORATION gain (loss) on derivative used in net investment hedge, after tax for fiscal 2020 was -$19.00M.
- BOSTON SCIENTIFIC CORPORATION gain (loss) on derivative used in net investment hedge, after tax for fiscal 2019 was -$33.00M.
| Period end | Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax 3 month | Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax 6 month | Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax 9 month | Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$8.00M 10-K · filed 2023-02-23 | |||
| 2021-12-31 | -$137.00M 10-K · filed 2023-02-23 | |||
| 2020-12-31 | -$5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | -$10.00M derived: sum of 2 quarters · filed 2022-02-23 | -$15.00M derived: sum of 3 quarters · filed 2022-02-23 | -$19.00M 10-K · filed 2022-02-23 |
| 2020-09-30 | -$5.00M 10-Q · filed 2020-11-05 | -$10.00M derived: sum of 2 quarters · filed 2020-11-05 | -$14.00M 10-Q · filed 2020-11-05 | -$23.00M derived: sum of 4 quarters · filed 2021-02-23 |
| 2020-06-30 | -$5.00M 10-Q · filed 2020-08-05 | -$9.00M 10-Q · filed 2020-08-05 | -$18.00M derived: sum of 3 quarters · filed 2021-02-23 | -$27.00M derived: sum of 4 quarters · filed 2021-02-23 |
| 2020-03-31 | -$5.00M 10-Q · filed 2020-05-06 | -$13.00M derived: sum of 2 quarters · filed 2021-02-23 | -$22.00M derived: sum of 3 quarters · filed 2021-02-23 | -$30.00M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-12-31 | -$8.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | -$17.00M derived: sum of 2 quarters · filed 2021-02-23 | -$25.00M derived: sum of 3 quarters · filed 2021-02-23 | -$33.00M 10-K · filed 2021-02-23 |
| 2019-09-30 | -$9.00M 10-Q · filed 2020-11-05 | -$17.00M derived: sum of 2 quarters · filed 2020-11-05 | -$25.00M 10-Q · filed 2020-11-05 | -$33.00M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | -$8.00M 10-Q · filed 2020-08-05 | -$16.00M 10-Q · filed 2020-08-05 | -$24.00M derived: sum of 3 quarters · filed 2020-08-05 | -$32.00M derived: sum of 4 quarters · filed 2020-08-05 |
| 2019-03-31 | -$8.00M 10-Q · filed 2020-05-06 | -$16.00M derived: sum of 2 quarters · filed 2020-05-06 | -$24.00M derived: sum of 3 quarters · filed 2020-05-06 | -$29.00M derived: sum of 4 quarters · filed 2020-05-06 |
| 2018-12-31 | -$8.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$16.00M derived: sum of 2 quarters · filed 2020-02-25 | -$21.00M derived: sum of 3 quarters · filed 2020-02-25 | -$21.00M 10-K · filed 2020-02-25 |
| 2018-09-30 | -$8.00M 10-Q · filed 2019-11-05 | -$13.00M derived: sum of 2 quarters · filed 2019-11-05 | -$13.00M 10-Q · filed 2019-11-05 | -$13.00M derived: sum of 4 quarters · filed 2019-11-05 |
| 2018-06-30 | -$5.00M 10-Q · filed 2019-07-30 | -$5.00M 10-Q · filed 2019-07-30 | -$5.00M derived: sum of 3 quarters · filed 2019-07-30 | -$5.00M derived: sum of 4 quarters · filed 2019-07-30 |
| 2018-03-31 | $0.00 10-Q · filed 2019-04-29 | $0.00 derived: sum of 2 quarters · filed 2019-04-29 | $0.00 derived: sum of 3 quarters · filed 2019-04-29 | $0.00 derived: sum of 4 quarters · filed 2019-04-29 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | $0.00 derived: sum of 2 quarters · filed 2019-02-19 | $0.00 derived: sum of 3 quarters · filed 2019-02-19 | $0.00 10-K · filed 2019-02-19 |
| 2017-09-30 | $0.00 10-Q · filed 2018-10-29 | $0.00 derived: sum of 2 quarters · filed 2018-10-29 | $0.00 10-Q · filed 2018-10-29 | |
| 2017-06-30 | $0.00 10-Q · filed 2018-07-31 | $0.00 10-Q · filed 2018-07-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |